Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6946 to 6960 of 8904 results

  1. HumiGard for preventing inadvertent perioperative hypothermia (MTG31)

    We have moved Medical technologies guidance 31 to become HealthTech guidance 428. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  2. Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27)

    We have moved Medical technologies guidance 27 to become HealthTech guidance 385. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  3. HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)

    We have moved Medical technologies guidance 32 to become HealthTech guidance 429. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  4. ENDURALIFE powered CRT-D devices for treating heart failure (MTG33)

    We have moved Medical technologies guidance 33 to become HealthTech guidance 433. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  5. SecurAcath for securing percutaneous catheters (MTG34)

    We have moved Medical technologies guidance 34 to become HealthTech guidance 440. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  6. Memokath-051 stent for ureteric obstruction (MTG35)

    This guidance has been updated and replaced by NICE healthtech guidance 651.

  7. Peristeen Plus transanal irrigation system for managing bowel dysfunction (MTG36)

    We have moved Medical technologies guidance 36 to become HealthTech guidance 462. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  8. Thopaz+ portable digital system for managing chest drains (MTG37)

    We have moved Medical technologies guidance 37 to become HealthTech guidance 465. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  9. Neuropad for detecting preclinical diabetic peripheral neuropathy (MTG38)

    We have moved Medical technologies guidance 38 to become HealthTech guidance 486. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  10. EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing (MTG12)

    We have moved medical technologies guidance 12 to become HealthTech guidance 296. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  11. SeQuent Please balloon catheter for in-stent coronary restenosis (MTG1)

    This medical technologies guidance has been replaced by the recommendations in the NICE guideline on acute coronary syndromes.

  12. Mega Soft Patient Return Electrode for use during monopolar electrosurgery (MTG11)

    We have moved medical technologies guidance 11 to become HealthTech guidance 290. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  13. Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms (MTG10)

    We have moved medical technologies guidance 10 to become HealthTech guidance 287. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  14. WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension (MTG13)

    In February 2023, NICE withdrew this guidance following a review. The original guidance published in 2013 and recommended the use of WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension. However the guidance review in 2022 recommended it be withdrawn because it was determined that: The existing medical technologies guidance was considered along with other interventions in the update of NICE's guideline on atrial fibrillation. See evidence review A and evidence review B providing the best advice to the NHS about its use. As evident in NICE's guideline on atrial fibrillation, the evidence base and experts’ advice, the landscape for opportunistically detecting atrial fibrillation in primary care has changed significantly since the original guidance, with a wider range of devices for detecting atrial fibrillation now available.

  15. E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta (MTG16)

    We have moved Medical technologies guidance 16 to become HealthTech guidance 326. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.